Blood component ratios in children with non‐traumatic life‐threatening bleeding. Issue 1 (25th November 2022)

• Record Type: Journal Article
• Authors: Marshall, Callie; Josephson, Cassandra D.; Leonard, Julie C.; Wisniewski, Stephen R.; Leeper, Christine M.; Luther, James F.; Spinella, Philip C.
• Is Part Of: Vox sanguinis. Volume 118:Issue 1(2023)
• Page Start: 68
• Page End: 75
• Publication Date: 2022-11-25
• Subjects: haemorrhage -- massive -- non‐traumatic -- paediatric -- ratios -- transfusion; Blood -- Periodicals; Blood -- Transfusion -- Periodicals; Immunohematology -- Periodicals; Immunopathology -- Periodicals; 615.39
• DOI: 10.1111/vox.13382
• Languages: English
• ISSNs: 0042-9007

Abstract

Abstract: Background and Objectives: In paediatric trauma patients, there are limited prospective data regarding blood components and mortality, with some literature suggesting decreased mortality with high ratios of plasma and platelets to red blood cells (RBCs) in massive transfusions; however, most paediatric massive transfusions occur for non‐traumatic aetiologies and few studies assess blood product ratios in these children. This study's objective was to evaluate whether high blood product ratios or low deficits conferred a survival benefit in children with non‐traumatic life‐threatening bleeding. Materials and Methods: This is a secondary analysis of the five‐year, multicentre, prospective, observational massive transfusion epidemiology and outcomes in children study of children with life‐threatening bleeding from US, Canadian and Italian medical centres. Primary interventions were plasma:RBC and platelets:RBC (high ratio ≥1:2 ml/kg) and plasma and platelet deficits. The primary outcome was mortality at 6 h, 24 h and 28 days. Multivariate logistic regression models were used to determine independent associations with mortality. Results: A total of 222 children were included from 24 medical centres: 145 children (median [interquartile range] age 2.1 years [0.3–11.8]) with operative bleeding and 77 (8.0 years [1.2–14.7]) with medical bleeding. In adjusted analyses, neither blood product ratios nor deficits were associated with mortality at 6 h, 24 h or 28 days. Conclusion: This paper addresses a lack of prospective data in children regarding optimal empiric massive transfusion strategies in non‐traumatic massive haemorrhage and in finding no decrease in mortality with high plasma or platelet to RBC ratios or lower deficits supports an exploratory analysis for mortality.